Trial Profile
A trial to evaluate ABI-009 (sirolimus) in patients with peripheral artery disease
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 08 Jul 2014
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions
- 08 Jul 2014 New trial record